ExosomePlus
About ExosomePlus
The startup develops a platform for the isolation and characterization of extracellular vesicles, specifically exosomes, to enhance regenerative therapies. By forming strategic partnerships with pharmaceutical companies, it enables the integration of exosomes into targeted treatments, improving therapeutic efficacy and versatility in addressing challenges within the pharmaceutical industry.
The startup develops a platform for the isolation and characterization of extracellular vesicles, specifically exosomes, to enhance regenerative therapies. By forming strategic partnerships with pharmaceutical companies, it enables the integration of exosomes into targeted treatments, improving therapeutic efficacy and versatility in addressing challenges within the pharmaceutical industry.
What does ExosomePlus do?
The startup develops a platform for the isolation and characterization of extracellular vesicles, specifically exosomes, to enhance regenerative therapies. By forming strategic partnerships with pharmaceutical companies, it enables the integration of exosomes into targeted treatments, improving therapeutic efficacy and versatility in addressing challenges within the pharmaceutical industry.
Where is ExosomePlus located?
ExosomePlus is based in Suwon, South Korea.
How much funding has ExosomePlus raised?
ExosomePlus has raised $2.4M.
- Location
- Suwon, South Korea
- Funding
- $2.4M
- Employees
- 2 employees